Cement body files appeal against Rs6.35b penalty
Although the current fiscal year has started on a promising note, the domestic despatches in July 2023 were approximately 20% lower than those in June 2023, said the APCMA spokesperson. photo: file
Listen to article
The All Pakistan Cement Manufacturers Association (APCMA) has filed an appeal with the Competition Appellate Tribunal, seeking the cancellation of Rs6.35 billion penalty imposed by the Competition Commission of Pakistan (CCP) on the APCMA and cement companies in a case pertaining to alleged price fixing and collusion.
The tribunal heard the case on Thursday, where Rashid Anwar, the counsel representing the APCMA, presented his arguments and dismissed the allegations.
He emphasised that there was a competitive landscape within the cement sector, characterised by differing prices. He described the CCP's decision against cement companies as unjust and pointed out that the commission had also imposed a notable fine on cement firms in 2009, when they were incurring losses.
Anwar argued that the CCP did not conduct a proper geographical analysis of the companies and the quota-sharing agreement between the companies had been signed in 2003 for two years only, which expired by the time the commission's decision came.
He contended that the CCP did not have reasonable grounds to raid the offices of the APCMA and its member companies. He requested the tribunal to invalidate the CCP decision.
The tribunal adjourned the hearing until May 22 following the conclusion of APCMA counsel's arguments. At the next hearing, the counsel representing different cement firms will put forth their arguments. Once they conclude, the CCP's legal representatives will defend the commission's ruling.
Earlier, the CCP had found evidence of agreements and collusion concerning the cement price determination and involving the APCMA. Following a comprehensive probe, the CCP slapped a fine of Rs6.35 billion on 20 cement manufacturers and the APCMA.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Recorder
a day ago
- Business Recorder
CCP grants two conditional exemptions to undertakings in transport, logistics sector
ISLAMABAD: The Competition Commission of Pakistan (CCP) has granted two conditional exemptions to undertakings in the transport and logistics sector, permitting limited restrictive provisions under joint venture agreements aimed at strengthening Pakistan's logistics capabilities. The exemptions were approved following a comprehensive review by CCP's Exemptions Department, which assessed the legal framework, potential market impact, and the long-term investment plans associated with the proposed collaborations. These arrangements were found to satisfy the requirements set out in Section 9 of the Competition Act, 2010. The joint ventures are expected to foster technical progress, enhance operational efficiency, and improve service standards in the logistics and freight sectors. The Commission observed that the joint ventures will leverage international best practices alongside local expertise, contributing to infrastructure development, innovation, and greater consumer value. Specific provisions within the shareholders' agreements—such as non-compete and exclusivity clauses—were conditionally approved to ensure investment protection and coordination, while safeguarding against risks of market foreclosure. These approvals reaffirm CCP's commitment to facilitating strategic business collaboration that supports economic growth, while ensuring that competition remains open, fair, and free from abuse of dominance. All exemptions are subject to strict compliance with conditions designed to preserve competitive dynamics in the market. Copyright Business Recorder, 2025
Business Recorder
2 days ago
- Business Recorder
CCP grants exemptions to logistics and transport sector
The Competition Commission of Pakistan (CCP) has granted two conditional exemptions to undertakings in the transport and logistics sector, permitting limited restrictive provisions under joint venture agreements aimed at strengthening Pakistan's logistics capabilities. According to a press statement released on Monday, the exemptions were approved following a comprehensive review by CCP's Exemptions Department, which assessed the legal framework, potential market impact, and the long-term investment plans associated with the proposed collaborations. 'These arrangements were found to satisfy the requirements set out in Section 9 of the Competition Act, 2010. The joint ventures are expected to foster technical progress, enhance operational efficiency, and improve service standards in the logistics and freight sectors,' read the statement. CCP grants six exemptions to pharma sector CCP observed that the joint ventures will leverage international best practices alongside local expertise, contributing to infrastructure development, innovation, and greater consumer value. Specific provisions within the shareholders' agreements—such as non-compete and exclusivity clauses—were conditionally approved to ensure investment protection and coordination, while safeguarding against risks of market foreclosure. These approvals reaffirm CCP's commitment to facilitating strategic business collaboration that supports economic growth, while ensuring that competition remains open, fair, and free from abuse of dominance, said CCP. 'All exemptions are subject to strict compliance with conditions designed to preserve competitive dynamics in the market,' read the statement.
Business Recorder
5 days ago
- Business Recorder
Pharmaceutical sector: CCP grants six exemptions to undertakings for FY2024–25
ISLAMABAD: In line with its mandate to promote fair competition and protect consumer welfare, the Competition Commission of Pakistan (CCP) has granted six exemptions to undertakings in the pharmaceutical sector for the fiscal year 2024–25, under Section 5 of the Competition Act, 2010. These exemptions relate to specific restrictive clauses in commercial agreements — such as territorial exclusivity and non-compete provisions that would ordinarily be considered anti-competitive under Section 4 (Prohibited Agreements) of the Act. However, after conducting rigorous due diligence, including a detailed assessment of market structures, sector-specific regulations, and the commercial terms of the agreements, CCP determined that the arrangements in question contribute to production efficiency, technological advancement, and enhanced consumer access to critical pharmaceutical products. The Commission noted that these exemptions are expected to improve service delivery, increase the availability of medicines in underserved regions, and lead to better public health outcomes. Consumers stand to benefit from access to advanced pharmaceutical technologies, more reliable product information, and higher standards of service. Each exemption was granted for a specific duration and is subject to conditions that ensure the pro-competitive benefits clearly outweigh any potential adverse effects on competition. Importantly, the undertakings are required to avoid any form of price-fixing or collusive conduct, and pricing arrangements remain outside the scope of these exemptions. The pharmaceutical sector remains a priority area for CCP's exemption regime, with the Commission maintaining close coordination with relevant health regulators to ensure that such decisions serve the broader public interest. Copyright Business Recorder, 2025
